Can you break down why there is such a push for making oral GLP-1s agonists
Substantial weight regain after discontinuation highlights the need to shift focus from short-term weight loss to long-term behavioral stabilization
In this post, we'll explore why retatrutide outperforms tirzepatide for weight loss, glucose regulation, fatty liver disease, and comprehensive metabolic health
Always label the vial with the date of reconstitution and the final concentration (e.g., "Retatrutide 10 mg/mL, Reconstituted on [Date]")
In a subanalysis of SURPASS-3, tirzepatide 10 and 15 mg resulted also in a relative reduction in liver fat content by 4047% compared to 11% with insulin glargine at 52 weeks [44]
What Actually Supports People Using GLP-1 Medications GLP-1 medications can meaningfully change appetite, meal size, and digestion